Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.85317465 |
2 | negative regulation of cell killing (GO:0031342) | 5.55936076 |
3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.55936076 |
4 | neutrophil activation involved in immune response (GO:0002283) | 4.66169008 |
5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.55291783 |
6 | negative T cell selection (GO:0043383) | 4.53141049 |
7 | negative thymic T cell selection (GO:0045060) | 4.45763669 |
8 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.41394816 |
9 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.41394816 |
10 | cellular response to interleukin-15 (GO:0071350) | 4.32302843 |
11 | response to interleukin-15 (GO:0070672) | 4.29618316 |
12 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.07799039 |
13 | negative regulation of T cell mediated immunity (GO:0002710) | 4.03838986 |
14 | microglial cell activation (GO:0001774) | 4.00926195 |
15 | response to peptidoglycan (GO:0032494) | 3.93546834 |
16 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.85947394 |
17 | positive T cell selection (GO:0043368) | 3.85609306 |
18 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.83431890 |
19 | immunoglobulin mediated immune response (GO:0016064) | 3.83038894 |
20 | respiratory burst (GO:0045730) | 3.78565367 |
21 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.74459410 |
22 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.74102995 |
23 | negative regulation of phagocytosis (GO:0050765) | 3.63091560 |
24 | activated T cell proliferation (GO:0050798) | 3.62390798 |
25 | positive regulation of granulocyte differentiation (GO:0030854) | 3.61129697 |
26 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.59983158 |
27 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.57396796 |
28 | positive regulation of B cell differentiation (GO:0045579) | 3.56486590 |
29 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.50487820 |
30 | positive regulation of interferon-alpha production (GO:0032727) | 3.49445749 |
31 | T cell selection (GO:0045058) | 3.49385059 |
32 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.48256441 |
33 | positive thymic T cell selection (GO:0045059) | 3.46447090 |
34 | neutrophil activation (GO:0042119) | 3.46265977 |
35 | autophagic vacuole fusion (GO:0000046) | 3.45966701 |
36 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.45605931 |
37 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.41254661 |
38 | response to interferon-beta (GO:0035456) | 3.41124040 |
39 | leukocyte aggregation (GO:0070486) | 3.39222281 |
40 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.36831093 |
41 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.36831093 |
42 | modulation by symbiont of host immune response (GO:0052553) | 3.36831093 |
43 | positive regulation by symbiont of host defense response (GO:0052509) | 3.36831093 |
44 | modulation by symbiont of host defense response (GO:0052031) | 3.36831093 |
45 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.36831093 |
46 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.36055015 |
47 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.34581504 |
48 | regulation of regulatory T cell differentiation (GO:0045589) | 3.34293555 |
49 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.34228784 |
50 | cellular response to interferon-beta (GO:0035458) | 3.33606273 |
51 | regulation of interferon-alpha production (GO:0032647) | 3.33193833 |
52 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.29743273 |
53 | myeloid dendritic cell activation (GO:0001773) | 3.25213351 |
54 | response to type I interferon (GO:0034340) | 3.24981453 |
55 | regulation of T cell tolerance induction (GO:0002664) | 3.24703328 |
56 | type I interferon signaling pathway (GO:0060337) | 3.24509357 |
57 | cellular response to type I interferon (GO:0071357) | 3.24509357 |
58 | positive regulation of antigen processing and presentation (GO:0002579) | 3.23355065 |
59 | granulocyte activation (GO:0036230) | 3.23295993 |
60 | regulation of B cell differentiation (GO:0045577) | 3.19627727 |
61 | tolerance induction (GO:0002507) | 3.16952386 |
62 | dendritic cell chemotaxis (GO:0002407) | 3.16867929 |
63 | detection of bacterium (GO:0016045) | 3.15562230 |
64 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.14814101 |
65 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.14814101 |
66 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.12145326 |
67 | cellular defense response (GO:0006968) | 3.10823013 |
68 | cellular response to zinc ion (GO:0071294) | 3.09715106 |
69 | T cell migration (GO:0072678) | 3.09050401 |
70 | regulation of tolerance induction (GO:0002643) | 3.08634997 |
71 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.08104049 |
72 | positive regulation of defense response to virus by host (GO:0002230) | 3.08000937 |
73 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.07671777 |
74 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.07445376 |
75 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.06087216 |
76 | organelle membrane fusion (GO:0090174) | 3.05389863 |
77 | mast cell activation (GO:0045576) | 3.05356168 |
78 | macrophage activation (GO:0042116) | 3.05072063 |
79 | thymic T cell selection (GO:0045061) | 3.01791143 |
80 | dendritic cell migration (GO:0036336) | 3.01190838 |
81 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.00787147 |
82 | superoxide anion generation (GO:0042554) | 3.00378028 |
83 | myeloid cell activation involved in immune response (GO:0002275) | 2.96152928 |
84 | mature B cell differentiation involved in immune response (GO:0002313) | 2.95605565 |
85 | B cell mediated immunity (GO:0019724) | 2.95420209 |
86 | regulation of RIG-I signaling pathway (GO:0039535) | 2.95080500 |
87 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.94979776 |
88 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.94196688 |
89 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.94191882 |
90 | pinocytosis (GO:0006907) | 2.93933573 |
91 | definitive hemopoiesis (GO:0060216) | 2.93565191 |
92 | cellular extravasation (GO:0045123) | 2.92569317 |
93 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.92230642 |
94 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.92188617 |
95 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.92188617 |
96 | positive regulation of tolerance induction (GO:0002645) | 2.90729200 |
97 | regulation of antigen processing and presentation (GO:0002577) | 2.89248813 |
98 | NIK/NF-kappaB signaling (GO:0038061) | 2.88702385 |
99 | neutrophil mediated immunity (GO:0002446) | 2.88261454 |
100 | defense response to protozoan (GO:0042832) | 2.86116955 |
101 | reactive oxygen species biosynthetic process (GO:1903409) | 2.84742136 |
102 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.84617441 |
103 | detection of external biotic stimulus (GO:0098581) | 2.82795439 |
104 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.82087154 |
105 | response to protozoan (GO:0001562) | 2.80549616 |
106 | negative regulation of interleukin-6 production (GO:0032715) | 2.80547615 |
107 | negative regulation of adaptive immune response (GO:0002820) | 2.79974767 |
108 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.79899853 |
109 | cytidine catabolic process (GO:0006216) | 2.78796512 |
110 | response to interferon-alpha (GO:0035455) | 2.78552452 |
111 | cellular response to exogenous dsRNA (GO:0071360) | 2.77701927 |
112 | positive regulation of interferon-beta production (GO:0032728) | 2.76754734 |
113 | megakaryocyte development (GO:0035855) | 2.76225920 |
114 | interferon-gamma production (GO:0032609) | 2.75566091 |
115 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.74824017 |
116 | response to muramyl dipeptide (GO:0032495) | 2.73970487 |
117 | actin nucleation (GO:0045010) | 2.73598108 |
118 | hepatocyte apoptotic process (GO:0097284) | 2.69712288 |
119 | regulation of mast cell activation (GO:0033003) | 2.69366154 |
120 | macrophage activation involved in immune response (GO:0002281) | 2.69026824 |
121 | negative regulation of interleukin-12 production (GO:0032695) | 2.68737479 |
122 | mature B cell differentiation (GO:0002335) | 2.66430655 |
123 | detection of other organism (GO:0098543) | 2.66289163 |
124 | B cell receptor signaling pathway (GO:0050853) | 2.65633004 |
125 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.63581832 |
126 | myeloid leukocyte activation (GO:0002274) | 2.63053918 |
127 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.62177764 |
128 | lipoxygenase pathway (GO:0019372) | 2.61766399 |
129 | myeloid dendritic cell differentiation (GO:0043011) | 2.61475060 |
130 | regulation of natural killer cell differentiation (GO:0032823) | 2.60793344 |
131 | leukocyte degranulation (GO:0043299) | 2.59704685 |
132 | germinal center formation (GO:0002467) | 2.57255673 |
133 | angiogenesis involved in wound healing (GO:0060055) | 2.56742543 |
134 | leukocyte mediated cytotoxicity (GO:0001909) | 2.55395111 |
135 | negative regulation of granulocyte differentiation (GO:0030853) | 2.55381645 |
136 | positive regulation of T cell migration (GO:2000406) | 2.55164694 |
137 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.49581607 |
138 | positive regulation of macrophage differentiation (GO:0045651) | 2.49288002 |
139 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.48956317 |
140 | response to host immune response (GO:0052572) | 2.48956317 |
141 | regulation of growth of symbiont in host (GO:0044126) | 2.48775092 |
142 | negative regulation of growth of symbiont in host (GO:0044130) | 2.48775092 |
143 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.48775092 |
144 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.48775092 |
145 | response to fungus (GO:0009620) | 2.48688229 |
146 | regulation of gamma-delta T cell activation (GO:0046643) | 2.47334358 |
147 | regulation of mast cell degranulation (GO:0043304) | 2.46373347 |
148 | positive regulation of mast cell activation (GO:0033005) | 2.45869825 |
149 | negative regulation of mast cell activation (GO:0033004) | 2.45410690 |
150 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.45309251 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.58700134 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.68429845 |
3 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.63440217 |
4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.22642882 |
5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.89730255 |
6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.83501978 |
7 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.37808471 |
8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.29483047 |
9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.23913443 |
10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.17367698 |
11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.07661060 |
12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.96620898 |
13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.94234705 |
14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.81236985 |
15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.77938276 |
16 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.74331956 |
17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.55005075 |
18 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.54238054 |
19 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.52487096 |
20 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.46518433 |
21 | GATA1_22025678_ChIP-Seq_K562_Human | 2.43897497 |
22 | * ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.39619285 |
23 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.38698619 |
24 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.12239836 |
25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.07956898 |
26 | MYB_26560356_Chip-Seq_TH2_Human | 2.06617402 |
27 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.06351013 |
28 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.99510745 |
29 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.99221610 |
30 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.92446471 |
31 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.88419204 |
32 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.85470417 |
33 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84050118 |
34 | MYB_26560356_Chip-Seq_TH1_Human | 1.80171710 |
35 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.79832319 |
36 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.79381693 |
37 | MAF_26560356_Chip-Seq_TH1_Human | 1.74781442 |
38 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.72167658 |
39 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.70639429 |
40 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.63259672 |
41 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62949064 |
42 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61381774 |
43 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61136205 |
44 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.59862866 |
45 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.59657221 |
46 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.57637320 |
47 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.50686846 |
48 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.50654972 |
49 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.47843508 |
50 | UTX_26944678_Chip-Seq_JUKART_Human | 1.40832388 |
51 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.40466515 |
52 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.39488759 |
53 | MYC_22102868_ChIP-Seq_BL_Human | 1.39296688 |
54 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.37990771 |
55 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.33675471 |
56 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.33290775 |
57 | SPI1_23127762_ChIP-Seq_K562_Human | 1.31727426 |
58 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30864962 |
59 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.30820511 |
60 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29685486 |
61 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.23910264 |
62 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.23592226 |
63 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19850979 |
64 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.19035985 |
65 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15989628 |
66 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15102496 |
67 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14555657 |
68 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.14523513 |
69 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.13643212 |
70 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13643013 |
71 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.12473101 |
72 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.11672018 |
73 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.10855518 |
74 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09758023 |
75 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.09647983 |
76 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08416341 |
77 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.07810074 |
78 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.07359199 |
79 | GATA1_19941826_ChIP-Seq_K562_Human | 1.07061891 |
80 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.06551319 |
81 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.03321546 |
82 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.03098567 |
83 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.02537451 |
84 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.01987202 |
85 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.00680051 |
86 | MAF_26560356_Chip-Seq_TH2_Human | 1.00091638 |
87 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99473895 |
88 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98167711 |
89 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.96866528 |
90 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.96389525 |
91 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.95118651 |
92 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.94780929 |
93 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.94581953 |
94 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.93834948 |
95 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.93513785 |
96 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.93120785 |
97 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.92641930 |
98 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.90299888 |
99 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.89908920 |
100 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.88338394 |
101 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.88264065 |
102 | * GATA3_26560356_Chip-Seq_TH1_Human | 0.87333959 |
103 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.87248501 |
104 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.87158280 |
105 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85100927 |
106 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.84832969 |
107 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.84542486 |
108 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.83849607 |
109 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.83110520 |
110 | AR_20517297_ChIP-Seq_VCAP_Human | 0.81960745 |
111 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.80988360 |
112 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.80729705 |
113 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.80728768 |
114 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.80413456 |
115 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.78978325 |
116 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78835012 |
117 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.78638775 |
118 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.77690543 |
119 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.77288859 |
120 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.76876810 |
121 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.75259718 |
122 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.74796440 |
123 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.74156612 |
124 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.73844632 |
125 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.73767692 |
126 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.73577179 |
127 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.73560135 |
128 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.72816110 |
129 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.72276360 |
130 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.72160588 |
131 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.71831497 |
132 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.70698997 |
133 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.70392159 |
134 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.69920976 |
135 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.69815399 |
136 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.69698596 |
137 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.68299086 |
138 | GATA2_19941826_ChIP-Seq_K562_Human | 0.66234460 |
139 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.64711462 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 4.45499442 |
2 | MP0003436_decreased_susceptibility_to | 3.34986649 |
3 | MP0009785_altered_susceptibility_to | 3.27094343 |
4 | MP0002148_abnormal_hypersensitivity_rea | 2.98930631 |
5 | * MP0002419_abnormal_innate_immunity | 2.86503769 |
6 | MP0005671_abnormal_response_to | 2.84728010 |
7 | MP0005000_abnormal_immune_tolerance | 2.76240637 |
8 | * MP0005025_abnormal_response_to | 2.75602057 |
9 | MP0003724_increased_susceptibility_to | 2.67448965 |
10 | MP0000685_abnormal_immune_system | 2.65522195 |
11 | MP0001800_abnormal_humoral_immune | 2.61153375 |
12 | MP0002396_abnormal_hematopoietic_system | 2.59871335 |
13 | * MP0002452_abnormal_antigen_presenting | 2.53188852 |
14 | MP0005387_immune_system_phenotype | 2.52624040 |
15 | MP0001790_abnormal_immune_system | 2.52624040 |
16 | * MP0002723_abnormal_immune_serum | 2.36233824 |
17 | * MP0002420_abnormal_adaptive_immunity | 2.31897820 |
18 | * MP0001819_abnormal_immune_cell | 2.31146427 |
19 | MP0005464_abnormal_platelet_physiology | 2.26680108 |
20 | MP0001853_heart_inflammation | 2.17046244 |
21 | MP0002166_altered_tumor_susceptibility | 2.08018274 |
22 | * MP0002398_abnormal_bone_marrow | 1.93480840 |
23 | MP0002405_respiratory_system_inflammati | 1.93300959 |
24 | MP0010155_abnormal_intestine_physiology | 1.87933785 |
25 | MP0002006_tumorigenesis | 1.84904156 |
26 | MP0006082_CNS_inflammation | 1.83692941 |
27 | * MP0000716_abnormal_immune_system | 1.83419850 |
28 | MP0003763_abnormal_thymus_physiology | 1.83010218 |
29 | MP0001533_abnormal_skeleton_physiology | 1.78123232 |
30 | MP0005174_abnormal_tail_pigmentation | 1.74882011 |
31 | MP0005058_abnormal_lysosome_morphology | 1.73746097 |
32 | MP0009333_abnormal_splenocyte_physiolog | 1.73111259 |
33 | * MP0001845_abnormal_inflammatory_respons | 1.68449869 |
34 | MP0000689_abnormal_spleen_morphology | 1.68427214 |
35 | MP0001545_abnormal_hematopoietic_system | 1.64848445 |
36 | MP0005397_hematopoietic_system_phenotyp | 1.64848445 |
37 | MP0003191_abnormal_cellular_cholesterol | 1.62316000 |
38 | MP0000465_gastrointestinal_hemorrhage | 1.59304025 |
39 | MP0004808_abnormal_hematopoietic_stem | 1.58989899 |
40 | * MP0002429_abnormal_blood_cell | 1.58884434 |
41 | MP0000343_altered_response_to | 1.56887244 |
42 | MP0002722_abnormal_immune_system | 1.55982452 |
43 | MP0003303_peritoneal_inflammation | 1.54489218 |
44 | MP0000858_altered_metastatic_potential | 1.50310809 |
45 | MP0004381_abnormal_hair_follicle | 1.49744344 |
46 | * MP0008469_abnormal_protein_level | 1.45208033 |
47 | MP0009764_decreased_sensitivity_to | 1.40442096 |
48 | MP0000490_abnormal_crypts_of | 1.38400908 |
49 | MP0004947_skin_inflammation | 1.36380068 |
50 | MP0003172_abnormal_lysosome_physiology | 1.34038060 |
51 | MP0004782_abnormal_surfactant_physiolog | 1.33592250 |
52 | MP0001873_stomach_inflammation | 1.33378238 |
53 | MP0003448_altered_tumor_morphology | 1.30892699 |
54 | MP0006054_spinal_hemorrhage | 1.28467318 |
55 | MP0003183_abnormal_peptide_metabolism | 1.28328209 |
56 | MP0000015_abnormal_ear_pigmentation | 1.24047847 |
57 | MP0003045_fibrosis | 1.22279550 |
58 | MP0003186_abnormal_redox_activity | 1.21103185 |
59 | MP0009278_abnormal_bone_marrow | 1.21033572 |
60 | MP0009840_abnormal_foam_cell | 1.19712195 |
61 | MP0008007_abnormal_cellular_replicative | 1.17156969 |
62 | MP0004510_myositis | 1.16407166 |
63 | MP0001986_abnormal_taste_sensitivity | 1.14239811 |
64 | MP0003300_gastrointestinal_ulcer | 1.11342996 |
65 | MP0008057_abnormal_DNA_replication | 1.11271059 |
66 | MP0005310_abnormal_salivary_gland | 1.11143633 |
67 | MP0002933_joint_inflammation | 1.10728576 |
68 | MP0003866_abnormal_defecation | 1.10419718 |
69 | MP0002877_abnormal_melanocyte_morpholog | 1.07023787 |
70 | MP0002998_abnormal_bone_remodeling | 1.05726969 |
71 | MP0003195_calcinosis | 1.05703180 |
72 | MP0000703_abnormal_thymus_morphology | 1.03744123 |
73 | MP0002876_abnormal_thyroid_physiology | 1.02963121 |
74 | MP0000569_abnormal_digit_pigmentation | 1.02445461 |
75 | MP0009763_increased_sensitivity_to | 1.01675453 |
76 | MP0002138_abnormal_hepatobiliary_system | 0.99942698 |
77 | MP0002693_abnormal_pancreas_physiology | 0.97601091 |
78 | MP0004130_abnormal_muscle_cell | 0.95398479 |
79 | MP0005075_abnormal_melanosome_morpholog | 0.94359031 |
80 | MP0002132_abnormal_respiratory_system | 0.94157222 |
81 | MP0002009_preneoplasia | 0.93689476 |
82 | MP0003279_aneurysm | 0.93173035 |
83 | MP0008260_abnormal_autophagy | 0.91846239 |
84 | MP0005390_skeleton_phenotype | 0.91805054 |
85 | MP0004147_increased_porphyrin_level | 0.91665924 |
86 | MP0003075_altered_response_to | 0.90658880 |
87 | MP0010094_abnormal_chromosome_stability | 0.89477266 |
88 | MP0001851_eye_inflammation | 0.85394312 |
89 | MP0005166_decreased_susceptibility_to | 0.85109905 |
90 | MP0000249_abnormal_blood_vessel | 0.83923477 |
91 | MP0000427_abnormal_hair_cycle | 0.83536861 |
92 | MP0002019_abnormal_tumor_incidence | 0.83443624 |
93 | MP0002095_abnormal_skin_pigmentation | 0.82387902 |
94 | MP0003787_abnormal_imprinting | 0.81827742 |
95 | MP0003943_abnormal_hepatobiliary_system | 0.81129349 |
96 | MP0001765_abnormal_ion_homeostasis | 0.77629681 |
97 | MP0010307_abnormal_tumor_latency | 0.77512265 |
98 | MP0008877_abnormal_DNA_methylation | 0.77427740 |
99 | MP0000371_diluted_coat_color | 0.76617405 |
100 | MP0003656_abnormal_erythrocyte_physiolo | 0.76559622 |
101 | MP0002928_abnormal_bile_duct | 0.76361135 |
102 | MP0003693_abnormal_embryo_hatching | 0.75147981 |
103 | MP0003828_pulmonary_edema | 0.74895460 |
104 | MP0003252_abnormal_bile_duct | 0.74336265 |
105 | MP0005164_abnormal_response_to | 0.72588540 |
106 | MP0008438_abnormal_cutaneous_collagen | 0.72347633 |
107 | MP0008058_abnormal_DNA_repair | 0.70155230 |
108 | MP0005023_abnormal_wound_healing | 0.69651807 |
109 | MP0002277_abnormal_respiratory_mucosa | 0.69042406 |
110 | MP0003795_abnormal_bone_structure | 0.67625726 |
111 | MP0003566_abnormal_cell_adhesion | 0.65983485 |
112 | MP0004883_abnormal_blood_vessel | 0.65882694 |
113 | MP0005379_endocrine/exocrine_gland_phen | 0.65797901 |
114 | MP0003077_abnormal_cell_cycle | 0.65078105 |
115 | MP0000604_amyloidosis | 0.64858547 |
116 | MP0002163_abnormal_gland_morphology | 0.64396942 |
117 | MP0002136_abnormal_kidney_physiology | 0.64003787 |
118 | MP0009765_abnormal_xenobiotic_induced | 0.62959927 |
119 | MP0000230_abnormal_systemic_arterial | 0.62554568 |
120 | MP0001663_abnormal_digestive_system | 0.62447603 |
121 | MP0008872_abnormal_physiological_respon | 0.61645487 |
122 | MP0005319_abnormal_enzyme/_coenzyme | 0.61323732 |
123 | MP0003690_abnormal_glial_cell | 0.59892944 |
124 | MP0001542_abnormal_bone_strength | 0.59029895 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 5.95186672 |
2 | Recurrent bacterial skin infections (HP:0005406) | 5.53358610 |
3 | Eczematoid dermatitis (HP:0000976) | 5.31194945 |
4 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.47901231 |
5 | Myositis (HP:0100614) | 4.30031176 |
6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.14017125 |
7 | Recurrent fungal infections (HP:0002841) | 3.87707841 |
8 | Recurrent viral infections (HP:0004429) | 3.67326847 |
9 | Recurrent skin infections (HP:0001581) | 3.65469146 |
10 | Mediastinal lymphadenopathy (HP:0100721) | 3.58318318 |
11 | Systemic lupus erythematosus (HP:0002725) | 3.56888034 |
12 | Orchitis (HP:0100796) | 3.49936721 |
13 | Optic neuritis (HP:0100653) | 3.36931143 |
14 | Retrobulbar optic neuritis (HP:0100654) | 3.36931143 |
15 | Abnormality of macrophages (HP:0004311) | 3.35372470 |
16 | Chronic otitis media (HP:0000389) | 3.34143473 |
17 | Thrombocytosis (HP:0001894) | 3.29166453 |
18 | Petechiae (HP:0000967) | 3.28386626 |
19 | Cellulitis (HP:0100658) | 3.23001525 |
20 | Meningitis (HP:0001287) | 3.13297029 |
21 | Autoimmune thrombocytopenia (HP:0001973) | 3.13051704 |
22 | Obstructive lung disease (HP:0006536) | 3.11549244 |
23 | Chronic obstructive pulmonary disease (HP:0006510) | 3.11549244 |
24 | Vacuolated lymphocytes (HP:0001922) | 3.09987562 |
25 | IgM deficiency (HP:0002850) | 3.06050560 |
26 | Autoimmune hemolytic anemia (HP:0001890) | 3.02481619 |
27 | Stomach cancer (HP:0012126) | 2.97379759 |
28 | Gingivitis (HP:0000230) | 2.97247088 |
29 | Spontaneous hematomas (HP:0007420) | 2.96794115 |
30 | Recurrent cutaneous fungal infections (HP:0011370) | 2.93657600 |
31 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.93657600 |
32 | Vasculitis (HP:0002633) | 2.85086202 |
33 | Glomerulonephritis (HP:0000099) | 2.79432167 |
34 | Increased IgE level (HP:0003212) | 2.79257470 |
35 | Pustule (HP:0200039) | 2.77764911 |
36 | Prolonged bleeding time (HP:0003010) | 2.76375644 |
37 | Reduced antithrombin III activity (HP:0001976) | 2.76060929 |
38 | Abnormality of the prostate (HP:0008775) | 2.67609401 |
39 | Recurrent bronchitis (HP:0002837) | 2.67069986 |
40 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.65651072 |
41 | Abnormality of T cell physiology (HP:0011840) | 2.62342723 |
42 | Periodontitis (HP:0000704) | 2.61672655 |
43 | Panhypogammaglobulinemia (HP:0003139) | 2.59589979 |
44 | Agammaglobulinemia (HP:0004432) | 2.59158531 |
45 | Keratoconjunctivitis sicca (HP:0001097) | 2.58352725 |
46 | Leukocytosis (HP:0001974) | 2.56912318 |
47 | Pulmonary infiltrates (HP:0002113) | 2.56541313 |
48 | Osteomyelitis (HP:0002754) | 2.56179475 |
49 | Epistaxis (HP:0000421) | 2.55404947 |
50 | Hypochromic anemia (HP:0001931) | 2.53572375 |
51 | Gingival bleeding (HP:0000225) | 2.52100951 |
52 | Aplastic anemia (HP:0001915) | 2.51735680 |
53 | Severe visual impairment (HP:0001141) | 2.46472993 |
54 | Alveolar cell carcinoma (HP:0006519) | 2.45797381 |
55 | Arterial thrombosis (HP:0004420) | 2.45382576 |
56 | Encephalitis (HP:0002383) | 2.44073497 |
57 | Recurrent pneumonia (HP:0006532) | 2.43033955 |
58 | Abnormality of T cells (HP:0002843) | 2.41894852 |
59 | Keratoconjunctivitis (HP:0001096) | 2.38008954 |
60 | Eosinophilia (HP:0001880) | 2.36188897 |
61 | Granulocytopenia (HP:0001913) | 2.35240542 |
62 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.33329021 |
63 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.32969307 |
64 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.32969307 |
65 | Abnormality of glycolipid metabolism (HP:0010969) | 2.32969307 |
66 | Congenital stationary night blindness (HP:0007642) | 2.32877743 |
67 | Increased IgM level (HP:0003496) | 2.31737980 |
68 | Stomatitis (HP:0010280) | 2.30469676 |
69 | Joint hemorrhage (HP:0005261) | 2.29686065 |
70 | Hypochromic microcytic anemia (HP:0004840) | 2.29623683 |
71 | Hyperlipoproteinemia (HP:0010980) | 2.29557258 |
72 | Decreased circulating renin level (HP:0003351) | 2.29357595 |
73 | Purpura (HP:0000979) | 2.28749830 |
74 | Hemoptysis (HP:0002105) | 2.26266061 |
75 | Lymphopenia (HP:0001888) | 2.25693738 |
76 | Thyroiditis (HP:0100646) | 2.24790439 |
77 | Anorexia (HP:0002039) | 2.24779933 |
78 | Urticaria (HP:0001025) | 2.23635938 |
79 | Pulmonary embolism (HP:0002204) | 2.23190991 |
80 | Abnormal platelet volume (HP:0011876) | 2.22581080 |
81 | Severe combined immunodeficiency (HP:0004430) | 2.22030957 |
82 | Inflammation of the large intestine (HP:0002037) | 2.21908471 |
83 | Abnormality of B cell number (HP:0010975) | 2.19345771 |
84 | B lymphocytopenia (HP:0010976) | 2.19345771 |
85 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.19333130 |
86 | Abnormality of T cell number (HP:0011839) | 2.18119861 |
87 | Prostate neoplasm (HP:0100787) | 2.17668327 |
88 | Recurrent lower respiratory tract infections (HP:0002783) | 2.17044572 |
89 | Chronic diarrhea (HP:0002028) | 2.15249914 |
90 | Abnormality of the pleura (HP:0002103) | 2.14389352 |
91 | Chromsome breakage (HP:0040012) | 2.14331939 |
92 | Microcytic anemia (HP:0001935) | 2.13584211 |
93 | Joint swelling (HP:0001386) | 2.13510824 |
94 | Abnormality of the pericardium (HP:0001697) | 2.13331599 |
95 | Large for gestational age (HP:0001520) | 2.13151486 |
96 | Polyneuropathy (HP:0001271) | 2.12034386 |
97 | Gangrene (HP:0100758) | 2.11891251 |
98 | Basal ganglia calcification (HP:0002135) | 2.11670552 |
99 | T lymphocytopenia (HP:0005403) | 2.11577181 |
100 | Abnormality of eosinophils (HP:0001879) | 2.10956774 |
101 | Type I transferrin isoform profile (HP:0003642) | 2.10332273 |
102 | Albinism (HP:0001022) | 2.07984588 |
103 | Gastrointestinal inflammation (HP:0004386) | 2.07175822 |
104 | Sepsis (HP:0100806) | 2.07091397 |
105 | Combined immunodeficiency (HP:0005387) | 2.05895169 |
106 | Colitis (HP:0002583) | 2.02421364 |
107 | Impaired platelet aggregation (HP:0003540) | 2.01466346 |
108 | Abnormal platelet function (HP:0011869) | 2.01466346 |
109 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.01447140 |
110 | Skin ulcer (HP:0200042) | 2.01062418 |
111 | IgG deficiency (HP:0004315) | 2.00920077 |
112 | Verrucae (HP:0200043) | 1.96207619 |
113 | Papilloma (HP:0012740) | 1.96207619 |
114 | Acute myeloid leukemia (HP:0004808) | 1.95263626 |
115 | Episodic fever (HP:0001954) | 1.95162226 |
116 | Hematochezia (HP:0002573) | 1.94603121 |
117 | Gastrointestinal stroma tumor (HP:0100723) | 1.93849302 |
118 | Abnormality of the renal cortex (HP:0011035) | 1.93659851 |
119 | Gastrointestinal infarctions (HP:0005244) | 1.93113099 |
120 | Chest pain (HP:0100749) | 1.92239234 |
121 | Nephritis (HP:0000123) | 1.91664180 |
122 | Patchy hypopigmentation of hair (HP:0011365) | 1.91220604 |
123 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.90885396 |
124 | Agnosia (HP:0010524) | 1.89825887 |
125 | Lymphoma (HP:0002665) | 1.89565971 |
126 | Interstitial pulmonary disease (HP:0006530) | 1.89434326 |
127 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.88837836 |
128 | Hypergammaglobulinemia (HP:0010702) | 1.88288586 |
129 | Abnormality of complement system (HP:0005339) | 1.87241981 |
130 | Acne (HP:0001061) | 1.84512569 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K14 | 3.67199586 |
2 | MAP4K1 | 3.39151871 |
3 | TYK2 | 2.87775104 |
4 | KIT | 2.82617620 |
5 | TXK | 2.81786655 |
6 | BLK | 2.77225993 |
7 | IRAK3 | 2.62870595 |
8 | TEC | 2.61779633 |
9 | * IRAK4 | 2.56704786 |
10 | BTK | 2.27180583 |
11 | TBK1 | 2.20079895 |
12 | JAK3 | 2.19499993 |
13 | PIM2 | 2.16058609 |
14 | IKBKE | 2.15524557 |
15 | IKBKB | 1.93734825 |
16 | TGFBR2 | 1.90657186 |
17 | ZAP70 | 1.81507614 |
18 | AKT3 | 1.74337989 |
19 | MARK3 | 1.71349665 |
20 | TAOK3 | 1.68536902 |
21 | CSF1R | 1.64664605 |
22 | EPHA3 | 1.61850695 |
23 | MAP2K6 | 1.58074171 |
24 | NEK9 | 1.55699783 |
25 | JAK1 | 1.52776068 |
26 | STK10 | 1.52143716 |
27 | SYK | 1.45959051 |
28 | PIM1 | 1.45896430 |
29 | RPS6KA4 | 1.42767810 |
30 | RIPK4 | 1.40837017 |
31 | NME2 | 1.39765710 |
32 | CHUK | 1.35995009 |
33 | TRPM7 | 1.35018310 |
34 | CSK | 1.33658090 |
35 | TNK2 | 1.30984662 |
36 | ERN1 | 1.28597449 |
37 | ITK | 1.27835698 |
38 | CLK1 | 1.27572100 |
39 | MAP2K3 | 1.23666463 |
40 | LYN | 1.20153725 |
41 | EIF2AK2 | 1.17760634 |
42 | ZAK | 1.16879818 |
43 | LCK | 1.10731699 |
44 | HCK | 1.10147408 |
45 | PIK3CG | 1.07217002 |
46 | MATK | 1.06608984 |
47 | TAF1 | 1.02151147 |
48 | HIPK2 | 1.00145564 |
49 | FLT3 | 0.98887943 |
50 | FGR | 0.97799778 |
51 | STK4 | 0.94961085 |
52 | VRK1 | 0.93638170 |
53 | GRK7 | 0.93042640 |
54 | FGFR3 | 0.88880832 |
55 | ADRBK2 | 0.86905995 |
56 | EIF2AK3 | 0.86611177 |
57 | MAP3K3 | 0.86005901 |
58 | SGK2 | 0.85039446 |
59 | FRK | 0.84234902 |
60 | TAOK1 | 0.83948322 |
61 | TLK1 | 0.82313746 |
62 | PTK2B | 0.79272987 |
63 | TIE1 | 0.78061644 |
64 | ERBB3 | 0.77419502 |
65 | MAP2K2 | 0.76608249 |
66 | NLK | 0.72005852 |
67 | KDR | 0.71781746 |
68 | EIF2AK1 | 0.70957093 |
69 | YES1 | 0.70102138 |
70 | GRK6 | 0.70061015 |
71 | RPS6KA6 | 0.69819751 |
72 | JAK2 | 0.67814550 |
73 | INSRR | 0.66402081 |
74 | BMPR2 | 0.66254229 |
75 | ATR | 0.65441302 |
76 | PDK1 | 0.63961639 |
77 | FES | 0.62850428 |
78 | MAP3K1 | 0.62080407 |
79 | EPHB1 | 0.61469005 |
80 | MAPKAPK2 | 0.61245722 |
81 | DAPK2 | 0.61093474 |
82 | LRRK2 | 0.61018744 |
83 | CDK6 | 0.60442752 |
84 | MAP3K13 | 0.60047300 |
85 | MAP3K12 | 0.58618475 |
86 | FGFR4 | 0.58215993 |
87 | CAMKK2 | 0.58007649 |
88 | RPS6KC1 | 0.57662425 |
89 | RPS6KL1 | 0.57662425 |
90 | TGFBR1 | 0.57012097 |
91 | MST4 | 0.55983860 |
92 | PRKCD | 0.55675913 |
93 | CAMKK1 | 0.54197784 |
94 | CDC42BPA | 0.54156787 |
95 | PRPF4B | 0.53236281 |
96 | SGK3 | 0.52707037 |
97 | MAP3K10 | 0.51931540 |
98 | PRKD2 | 0.51511604 |
99 | NUAK1 | 0.48185897 |
100 | STK11 | 0.47747419 |
101 | MYLK | 0.46341657 |
102 | PLK4 | 0.45866409 |
103 | IRAK1 | 0.45791600 |
104 | MAPK12 | 0.45523780 |
105 | GRK1 | 0.45503212 |
106 | BRSK2 | 0.44707189 |
107 | ADRBK1 | 0.44394910 |
108 | MAPKAPK3 | 0.44392560 |
109 | MAPK7 | 0.41821471 |
110 | MAP3K11 | 0.41590854 |
111 | ABL1 | 0.41471665 |
112 | PAK4 | 0.41299048 |
113 | MAP3K2 | 0.40422166 |
114 | MELK | 0.39903451 |
115 | SIK2 | 0.39298687 |
116 | PRKCQ | 0.39298034 |
117 | PTK6 | 0.37961273 |
118 | MAP3K7 | 0.37792251 |
119 | MKNK1 | 0.37507748 |
120 | MAPK11 | 0.36640734 |
121 | PASK | 0.35329277 |
122 | IGF1R | 0.34331280 |
123 | SGK223 | 0.33554220 |
124 | SGK494 | 0.33554220 |
125 | CDK4 | 0.33326443 |
126 | ACVR1B | 0.32485001 |
127 | PAK3 | 0.32105964 |
128 | RPS6KA5 | 0.32093195 |
129 | CDK8 | 0.31789871 |
130 | PDPK1 | 0.31584138 |
131 | STK24 | 0.31326501 |
132 | SIK3 | 0.31076742 |
133 | MAPK4 | 0.30767415 |
134 | FYN | 0.28160665 |
135 | EEF2K | 0.27912374 |
136 | ABL2 | 0.27802768 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * Leishmaniasis_Homo sapiens_hsa05140 | 2.80323541 |
2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.79041705 |
3 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.55292971 |
4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.54104867 |
5 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.34035187 |
6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.29965985 |
7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.15778455 |
8 | * Measles_Homo sapiens_hsa05162 | 2.11639487 |
9 | DNA replication_Homo sapiens_hsa03030 | 2.11456639 |
10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.04181939 |
11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.01099461 |
12 | Legionellosis_Homo sapiens_hsa05134 | 1.99273347 |
13 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.90367602 |
14 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.90215634 |
15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.85027242 |
16 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.84710214 |
17 | * Pertussis_Homo sapiens_hsa05133 | 1.84593710 |
18 | Other glycan degradation_Homo sapiens_hsa00511 | 1.82462119 |
19 | Allograft rejection_Homo sapiens_hsa05330 | 1.78770212 |
20 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.78271178 |
21 | Malaria_Homo sapiens_hsa05144 | 1.74351214 |
22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.73370516 |
23 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.70324813 |
24 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.62297183 |
25 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.60319454 |
26 | Base excision repair_Homo sapiens_hsa03410 | 1.57290297 |
27 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.54049564 |
28 | * Influenza A_Homo sapiens_hsa05164 | 1.42420998 |
29 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.42239560 |
30 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.42138616 |
31 | * Tuberculosis_Homo sapiens_hsa05152 | 1.40063247 |
32 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.36995537 |
33 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.33895148 |
34 | Apoptosis_Homo sapiens_hsa04210 | 1.33327446 |
35 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.32816079 |
36 | Asthma_Homo sapiens_hsa05310 | 1.28898830 |
37 | * Toxoplasmosis_Homo sapiens_hsa05145 | 1.28692969 |
38 | Mismatch repair_Homo sapiens_hsa03430 | 1.26610195 |
39 | Lysosome_Homo sapiens_hsa04142 | 1.20153000 |
40 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.16117375 |
41 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.14442400 |
42 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.13922986 |
43 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.12756737 |
44 | Salmonella infection_Homo sapiens_hsa05132 | 1.09592257 |
45 | Homologous recombination_Homo sapiens_hsa03440 | 1.09431082 |
46 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.08565591 |
47 | Shigellosis_Homo sapiens_hsa05131 | 1.08463579 |
48 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.08007434 |
49 | Hepatitis B_Homo sapiens_hsa05161 | 1.06151985 |
50 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.03776265 |
51 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.01415404 |
52 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.01117189 |
53 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.00769652 |
54 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.98071116 |
55 | Phagosome_Homo sapiens_hsa04145 | 0.92081026 |
56 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.92003071 |
57 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.90152131 |
58 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.90049509 |
59 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.89756889 |
60 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.89026565 |
61 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.86581376 |
62 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.86454480 |
63 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.85679147 |
64 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.83571772 |
65 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.82984453 |
66 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.80993862 |
67 | Hepatitis C_Homo sapiens_hsa05160 | 0.80651663 |
68 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.78889842 |
69 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.78323989 |
70 | Viral myocarditis_Homo sapiens_hsa05416 | 0.77873721 |
71 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.77794379 |
72 | Platelet activation_Homo sapiens_hsa04611 | 0.75154400 |
73 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.74920557 |
74 | ABC transporters_Homo sapiens_hsa02010 | 0.74655161 |
75 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.74104499 |
76 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.72773429 |
77 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.72756046 |
78 | Ribosome_Homo sapiens_hsa03010 | 0.72609768 |
79 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.72538679 |
80 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.69662769 |
81 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.68203471 |
82 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.66314085 |
83 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.66079722 |
84 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.64572104 |
85 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.61652419 |
86 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.60527246 |
87 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.59747913 |
88 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.59530187 |
89 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.59156875 |
90 | Protein export_Homo sapiens_hsa03060 | 0.58394277 |
91 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.58167819 |
92 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.57982527 |
93 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.56430854 |
94 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.56235509 |
95 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.55479863 |
96 | Galactose metabolism_Homo sapiens_hsa00052 | 0.55225787 |
97 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.54876367 |
98 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.52627903 |
99 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.52340135 |
100 | Phototransduction_Homo sapiens_hsa04744 | 0.51829765 |
101 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.51036561 |
102 | HTLV-I infection_Homo sapiens_hsa05166 | 0.50589496 |
103 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.49174651 |
104 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.49093446 |
105 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.48409392 |
106 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.46976660 |
107 | Cell cycle_Homo sapiens_hsa04110 | 0.46031015 |
108 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.45606142 |
109 | RNA degradation_Homo sapiens_hsa03018 | 0.45554597 |
110 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.44885154 |
111 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.44758907 |
112 | Insulin resistance_Homo sapiens_hsa04931 | 0.44318130 |
113 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.44030049 |
114 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.43280736 |
115 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.41546537 |
116 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.40948386 |
117 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.39945673 |
118 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39384960 |
119 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.39345059 |
120 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.38365394 |
121 | Amoebiasis_Homo sapiens_hsa05146 | 0.36139883 |
122 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.34381189 |
123 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.34349155 |
124 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.33775155 |
125 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.33287417 |
126 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.32796602 |
127 | Proteasome_Homo sapiens_hsa03050 | 0.32670634 |
128 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.32249537 |
129 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.32105024 |
130 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.31889303 |
131 | Endocytosis_Homo sapiens_hsa04144 | 0.30996746 |
132 | Prostate cancer_Homo sapiens_hsa05215 | 0.30425356 |
133 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.28752966 |
134 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.27455347 |
135 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.26672204 |
136 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.25976425 |